Suppr超能文献

连接造血干细胞和成熟巨核细胞的单能巨核细胞生成途径。

Unipotent Megakaryopoietic Pathway Bridging Hematopoietic Stem Cells and Mature Megakaryocytes.

作者信息

Nishikii Hidekazu, Kanazawa Yosuke, Umemoto Terumasa, Goltsev Yury, Matsuzaki Yu, Matsushita Kenji, Yamato Masayuki, Nolan Garry P, Negrin Robert, Chiba Shigeru

机构信息

Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.

Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.

出版信息

Stem Cells. 2015 Jul;33(7):2196-207. doi: 10.1002/stem.1985. Epub 2015 Apr 27.

Abstract

Recent identification of platelet/megakaryocyte-biased hematopoietic stem/repopulating cells requires revision of the intermediate pathway for megakaryopoiesis. Here, we show a unipotent megakaryopoietic pathway bypassing the bipotent megakaryocyte/erythroid progenitors (biEMPs). Cells purified from mouse bone marrow by CD42b (GPIbα) marking were demonstrated to be unipotent megakaryocytic progenitors (MKPs) by culture and transplantation. A subpopulation of freshly isolated CD41(+) cells in the lineage Sca1(+) cKit(+) (LSK) fraction (subCD41(+) LSK) differentiated only into MKP and mature megakaryocytes in culture. Although CD41(+) LSK cells as a whole were capable of differentiating into all myeloid and lymphoid cells in vivo, they produced unipotent MKP, mature megakaryocytes, and platelets in vitro and in vivo much more efficiently than Flt3(+) CD41(-) LSK cells, especially at the early phase after transplantation. In single cell polymerase chain reaction and thrombopoietin (TPO) signaling analyses, the MKP and a fraction of CD41(+) LSK, but not the biEMP, showed the similarities in mRNA expression profile and visible TPO-mediated phosphorylation. On increased demand of platelet production after 5-FU treatment, a part of CD41(+) LSK population expressed CD42b on the surface, and 90% of them showed unipotent megakaryopoietic capacity in single cell culture and predominantly produced platelets in vivo at the early phase after transplantation. These results suggest that the CD41(+) CD42b(+) LSK are straightforward progenies of megakaryocytes/platelet-biased stem/repopulating cells, but not progenies of biEMP. Consequently, we show a unipotent/highly biased megakaryopoietic pathway interconnecting stem/repopulating cells and mature megakaryocytes, the one that may play physiologic roles especially in emergency megakaryopoiesis.

摘要

最近对血小板/巨核细胞偏向性造血干细胞/再填充细胞的鉴定需要对巨核细胞生成的中间途径进行修订。在此,我们展示了一条绕过双能巨核细胞/红系祖细胞(biEMP)的单能巨核细胞生成途径。通过CD42b(糖蛋白Ibα)标记从小鼠骨髓中纯化的细胞,经培养和移植证明是单能巨核细胞祖细胞(MKP)。谱系Sca1(+) cKit(+)(LSK)组分中新鲜分离的CD41(+)细胞亚群(subCD41(+) LSK)在培养中仅分化为MKP和成熟巨核细胞。尽管CD41(+) LSK细胞整体在体内能够分化为所有髓系和淋巴细胞,但它们在体外和体内产生单能MKP、成熟巨核细胞和血小板的效率比Flt3(+) CD41(-) LSK细胞高得多,尤其是在移植后的早期阶段。在单细胞聚合酶链反应和血小板生成素(TPO)信号分析中,MKP和一部分CD41(+) LSK,而非biEMP,在mRNA表达谱和可见的TPO介导的磷酸化方面表现出相似性。在5-氟尿嘧啶处理后血小板生成需求增加时,一部分CD41(+) LSK群体在表面表达CD42b,其中90%在单细胞培养中表现出单能巨核细胞生成能力,并且在移植后的早期阶段在体内主要产生血小板。这些结果表明,CD41(+) CD42b(+) LSK是巨核细胞/血小板偏向性干细胞/再填充细胞的直接后代,而非biEMP的后代。因此,我们展示了一条连接干细胞/再填充细胞和成熟巨核细胞的单能/高度偏向性巨核细胞生成途径,该途径可能尤其在紧急巨核细胞生成中发挥生理作用。

相似文献

1
Unipotent Megakaryopoietic Pathway Bridging Hematopoietic Stem Cells and Mature Megakaryocytes.
Stem Cells. 2015 Jul;33(7):2196-207. doi: 10.1002/stem.1985. Epub 2015 Apr 27.
2
3
OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets.
PLoS One. 2013;8(3):e58123. doi: 10.1371/journal.pone.0058123. Epub 2013 Mar 1.
4
The Road Map for Megakaryopoietic Lineage from Hematopoietic Stem/Progenitor Cells.
Stem Cells Transl Med. 2017 Aug;6(8):1661-1665. doi: 10.1002/sctm.16-0490. Epub 2017 Jul 6.
5
Identification of unipotent megakaryocyte progenitors in human hematopoiesis.
Blood. 2017 Jun 22;129(25):3332-3343. doi: 10.1182/blood-2016-09-741611. Epub 2017 Mar 23.
6
Characterization of thrombopoietin (TPO)-responsive progenitor cells in adult mouse bone marrow with in vivo megakaryocyte and erythroid potential.
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2364-9. doi: 10.1073/pnas.1121385109. Epub 2012 Jan 30.
7
CD45 expression discriminates waves of embryonic megakaryocytes in the mouse.
Haematologica. 2019 Sep;104(9):1853-1865. doi: 10.3324/haematol.2018.192559. Epub 2018 Dec 20.
9
Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells.
J Cell Physiol. 2000 Jul;184(1):58-69. doi: 10.1002/(SICI)1097-4652(200007)184:1<58::AID-JCP6>3.0.CO;2-B.
10

引用本文的文献

1
Long-lived lung megakaryocytes contribute to platelet recovery in thrombocytopenia models.
J Clin Invest. 2024 Sep 19;134(22):e181111. doi: 10.1172/JCI181111.
2
Early megakaryocyte lineage-committed progenitors in adult mouse bone marrow.
Blood Sci. 2024 May 7;6(2):e00187. doi: 10.1097/BS9.0000000000000187. eCollection 2024 Apr.
3
Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial.
Ann Hematol. 2023 Oct;102(10):2895-2902. doi: 10.1007/s00277-023-05410-3. Epub 2023 Aug 17.
4
Intraosseous delivery of platelet-targeted factor VIII lentiviral vector in humanized NBSGW mice.
Blood Adv. 2022 Oct 11;6(19):5556-5569. doi: 10.1182/bloodadvances.2022008079.
5
Developmental cues license megakaryocyte priming in murine hematopoietic stem cells.
Blood Adv. 2022 Dec 27;6(24):6228-6241. doi: 10.1182/bloodadvances.2021006861.
6
Differentiation Epitopes Define Hematopoietic Stem Cells and Change with Cell Cycle Passage.
Stem Cell Rev Rep. 2022 Oct;18(7):2351-2364. doi: 10.1007/s12015-022-10374-4. Epub 2022 May 3.
7
Genetics of inherited thrombocytopenias.
Blood. 2022 Jun 2;139(22):3264-3277. doi: 10.1182/blood.2020009300.
8
DMAG, a novel countermeasure for the treatment of thrombocytopenia.
Mol Med. 2021 Nov 27;27(1):149. doi: 10.1186/s10020-021-00404-1.
9
CD62L expression level determines the cell fate of myeloid progenitors.
Stem Cell Reports. 2021 Dec 14;16(12):2871-2886. doi: 10.1016/j.stemcr.2021.10.012. Epub 2021 Nov 18.
10
Study of inherited thrombocytopenia resulting from mutations in ETV6 or RUNX1 using a human pluripotent stem cell model.
Stem Cell Reports. 2021 Jun 8;16(6):1458-1467. doi: 10.1016/j.stemcr.2021.04.013. Epub 2021 May 20.

本文引用的文献

2
Thrombopoietin from beginning to end.
Br J Haematol. 2014 Apr;165(2):259-68. doi: 10.1111/bjh.12772. Epub 2014 Feb 6.
4
Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy.
Nature. 2013 Oct 10;502(7470):232-6. doi: 10.1038/nature12495. Epub 2013 Aug 11.
5
Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.
Br J Haematol. 2013 Jun;161(6):778-93. doi: 10.1111/bjh.12328. Epub 2013 Apr 18.
6
CD41 expression marks myeloid-biased adult hematopoietic stem cells and increases with age.
Blood. 2013 May 30;121(22):4463-72. doi: 10.1182/blood-2012-09-457929. Epub 2013 Apr 5.
7
The endothelial antigen ESAM monitors hematopoietic stem cell status between quiescence and self-renewal.
J Immunol. 2012 Jul 1;189(1):200-10. doi: 10.4049/jimmunol.1200056. Epub 2012 May 30.
8
Distinct B-cell lineage commitment distinguishes adult bone marrow hematopoietic stem cells.
Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5394-8. doi: 10.1073/pnas.1121632109. Epub 2012 Mar 19.
9
Characterization of thrombopoietin (TPO)-responsive progenitor cells in adult mouse bone marrow with in vivo megakaryocyte and erythroid potential.
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2364-9. doi: 10.1073/pnas.1121385109. Epub 2012 Jan 30.
10
Crosstalk between NOTCH and AKT signaling during murine megakaryocyte lineage specification.
Blood. 2011 Aug 4;118(5):1264-73. doi: 10.1182/blood-2011-01-328567. Epub 2011 Jun 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验